|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 545 articles |
 Page 1 of 8 
|
Cangene enters SARS R&D deal.
June 30, 2003
SuperGen's $21.25M placing.
June 30, 2003
Bayer Biological gains Gamunex trade mark.
June 30, 2003
Abbott sponsors free HIV testing program.
June 30, 2003
IGEN gets $23 million multi-year contract from US Army.
June 30, 2003
New CM facility for KS Avicenna.
June 30, 2003
Merckle's licofelone may offer benefits over current osteoarthritis tr...
June 30, 2003
Bayer AG offering contract biotech manufacturing.
June 30, 2003
UPDATE - France to reimburse drugs at generics prices.
June 30, 2003
Wyeth's Enbrel effective in AS.
June 30, 2003
Abbott's Humira in early/established RA.
June 30, 2003
The informed patient is straining relations with doctors, pharma warne...
June 30, 2003
As US Congress Medicare Rx benefit votes near, House proposes means-te...
June 30, 2003
Genmab grants employees warrants.
June 30, 2003
GlycoGenesys achieves Nasdaq compliance.
June 30, 2003
Transition Thera completes C$5.4M placing.
June 30, 2003
Chrysalis BioTech awarded NIH grant for novel peptide.
June 30, 2003
Tokyo pharma stocks - week to June 23.
June 30, 2003
Biogen and IDEC consolidate pipeline in $6.7 billion biotech merger.
June 30, 2003
EU clears Lilly's Forsteo for osteoporosis.
June 30, 2003
B-MS gets FDA OK for Reyataz.
June 30, 2003
Lilly's Gemzar cleared for breast cancer.
June 30, 2003
Orion's PD therapy is approved by FDA.
June 30, 2003
South African govt backs generics.
June 30, 2003
US/industry drug access deal "near".
June 30, 2003
Wyeth's Enbrel effective in AS.
June 30, 2003
Novartis' Prexige benefits OA patients.
June 30, 2003
Abbott's Humira in early/established RA.
June 30, 2003
Pfizer's Bextra gives lower medical costs.
June 30, 2003
Merck & Co's Proscar cuts prostate cancer risk.
June 30, 2003
Roche launches gene test to predict drug reactions.
June 30, 2003
Ranbaxy raises stake in Chinese JV.
June 30, 2003
Sankyo to cut costs by $85M with new plan.
June 30, 2003
Roche to release a new drug each year in Japan.
June 30, 2003
Promotions at Abbott Labs.
June 30, 2003
FDA tells J&J, GSK and Allergan to pull misleading ads.
June 30, 2003
GlaxoSmithKline names Rodrigo Becker as president of Spanish subsidiar...
June 30, 2003
MediGene closes US R&D unit to save costs.
June 30, 2003
Aventis acquires global rights to ZP10.
June 30, 2003
US FDA grants Adprotech's APT070 Orphan Drug Status in organ transplan...
June 30, 2003
Avidex able to generate T cell receptors with high affinity and specif...
June 30, 2003
FDA approves several generic forms of Remeron.
June 30, 2003
King receives approval of sNDA for AtroPen.
June 30, 2003
Zhejiang Huahai's AIDS drugs approved in China.
June 30, 2003
AstraZeneca's Zomig nasal spray provides fast migraine relief.
June 30, 2003
Columbia's Striant cleared as a testosterone replacement therapy.
June 30, 2003
Akzo Nobel nominates Rob Frohn as new chief financial officer.
June 30, 2003
French drug industry body names new board members.
June 30, 2003
Protherics appoints Enact's Toony Atkinson as chief scientific officer...
June 30, 2003
LION Bioscience names Klaus Pohle to supervisory board.
June 30, 2003
Lithuanian biotech firm Fermentas sets up international holding co.
June 30, 2003
Curacyte discovers novel anticancer agents.
June 30, 2003
South African govt backs generics.
June 30, 2003
UPDATE: US/industry drug access deal "near".
June 30, 2003
SARS boost for Chinese pharma in May.
June 30, 2003
SPECTRUM.
June 30, 2003
Stock Commentary - Europe.
June 30, 2003
Stock Commentary - Tokyo.
June 30, 2003
Stock Commentary - New York.
June 30, 2003
GSK remuneration talks underway.
June 30, 2003
Elan shareholders approve sale to King.
June 30, 2003
France's Leclerc to set up pharmacies.
June 30, 2003
Chiesi Spain to acquire Alcala division.
June 30, 2003
Trial launched to investigate infliximab in RA prevention.
June 30, 2003
Cell Thera prices $75M ofering.
June 30, 2003
Amlyin prices $150M private placement.
June 30, 2003
CEl-SCI receives funds from partner Eastern Biotech.
June 30, 2003
Zeltia's ES-285 goes into the clinic.
June 30, 2003
New use for Sanofi/ Organon's Arixtra.
June 30, 2003
FDA OKs MedImmune and Wyeth's FluMist.
June 30, 2003
Spain's Puleva Biotech sees revenues rising 20-fold by 2008.
June 30, 2003
S African High Court to rule on dispensing.
June 30, 2003
NZ govt told: "spend on disease to save".
June 30, 2003
Japanese convenience stores to sell OTCs.
June 30, 2003
New firm in Zambia to provide cheap drugs.
June 30, 2003
|
1